Genes (May 2020)

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis

  • Zhongyu Liu,
  • Justin D. Anderson,
  • Lily Deng,
  • Stephen Mackay,
  • Johnathan Bailey,
  • Latona Kersh,
  • Steven M. Rowe,
  • Jennifer S. Guimbellot

DOI
https://doi.org/10.3390/genes11060603
Journal volume & issue
Vol. 11, no. 6
p. 603

Abstract

Read online

We describe a human nasal epithelial (HNE) organoid model derived directly from patient samples that is well-differentiated and recapitulates the airway epithelium, including the expression of cilia, mucins, tight junctions, the cystic fibrosis transmembrane conductance regulator (CFTR), and ionocytes. This model requires few cells compared to airway epithelial monolayer cultures, with multiple outcome measurements depending on the application. A novel feature of the model is the predictive capacity of lumen formation, a marker of baseline CFTR function that correlates with short-circuit current activation of CFTR in monolayers and discriminates the cystic fibrosis (CF) phenotype from non-CF. Our HNE organoid model is amenable to automated measurements of forskolin-induced swelling (FIS), which distinguishes levels of CFTR activity. While the apical side is not easily accessible, RNA- and DNA-based therapies intended for systemic administration could be evaluated in vitro, or it could be used as an ex vivo biomarker of successful repair of a mutant gene. In conclusion, this highly differentiated airway epithelial model could serve as a surrogate biomarker to assess correction of the mutant gene in CF or other diseases, recapitulating the phenotypic and genotypic diversity of the population.

Keywords